Stock listing
NASDAQ:SBPH Spring Bank Pharmaceuticals Inc Stock
Follow Spring Bank Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted NASDAQ:SBPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SBPH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Spring Bank Pharmaceuticals Inc on 6ix
- Decks
- 12 decks · latest Nov 10, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| F-star Therapeutics — Investor Presentation (November 2021) | Investor deck | 29 slides | Nov 10, 2021 |
| F-star Therapeutics — Q3 2021 Earnings Presentation | Earnings | 26 slides | Aug 12, 2021 |
| F-star Therapeutics — FY2020 Earnings Presentation | Earnings | 10 slides | Apr 5, 2021 |
| F-star Therapeutics — Investor Presentation (November 2020) | Investor deck | 31 slides | Nov 20, 2020 |
| Merger or Acquisition (August 2020) | Merger or acquisition | 38 slides | Aug 12, 2020 |
| Merger or Acquisition (July 2020) | Merger or acquisition | 20 slides | Jul 30, 2020 |
| Corporate Update (April 2019) | Corporate update | 22 slides | Apr 12, 2019 |
| Investor Presentation (November 2018) | Investor deck | 31 slides | Nov 6, 2018 |
| Corporate Update (August 2018) | Corporate update | 19 slides | Aug 2, 2018 |
| Investor Presentation (April 2018) | Investor deck | 22 slides | Apr 25, 2018 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2017) | Investor deck | 28 slides | Sep 21, 2017 |
| IPO Roadshow (April 2016) | IPO roadshow | 19 slides | Apr 29, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Arkowitz Other companies: iBio, Inc. (Director · Since at least Nov 21, 2024); Kineta Inc. (Director · Since at least Mar 6, 2019); Seres Therapeutics, Inc. (Chief Financial Officer · Jun 1, 2021 – Feb 14, 2024 · Past); Flexion Therapeutics Inc (Chief Financial Officer · May 7, 2018 – May 10, 2021 · Past); AMAG Pharmaceuticals Inc (EVP, CFO and CBO · Apr 5, 2007 – May 31, 2011 · Past); Idenix Pharmaceuticals Inc (Chief Financial Officer · Mar 7, 2006 – Mar 6, 2007 · Past) | Director · May 5, 2016 – Jun 24, 2020 · Past |
| Todd C. Brady Other companies: Contineum Therapeutics, Inc. (Director · Since at least Apr 4, 2024); Aldeyra Therapeutics, Inc. (Chief Executive Officer, President & Director · Since at least May 1, 2014); Evoke Pharma Inc (Director · Since at least Sep 24, 2013); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 11, 2020 · Past); Cocrystal Pharma, Inc. (Director · Feb 1, 2019 – Feb 1, 2019 · Past); Outlook Therapeutics, Inc. (Director · May 12, 2016 – Oct 26, 2017 · Past) | Director · Jul 28, 2016 – Sep 30, 2020 · Past |
| Scott A. Smith Other companies: Viatris Inc. (Chief Executive Officer · Since at least Dec 29, 2022); BioAtla, Inc. (Director · Since at least Dec 15, 2020); Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past); Titan Pharmaceuticals Inc (Director · Jan 2, 2017 – Sep 15, 2017 · Past); Celgene Corporation (See Remarks · Aug 1, 2014 – Feb 17, 2018 · Past) | Director · Aug 15, 2018 – Jun 24, 2020 · Past |
| Timothy P Clackson Other companies: Elevation Oncology Inc (Director · Since at least Jun 24, 2021); Theseus Pharmaceuticals Inc (President and CEO, Director · Oct 6, 2021 – Mar 1, 2023 · Past); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Oct 14, 2022 · Past); Ariad Pharmaceuticals Inc (President, R&D, CSO · Mar 10, 2006 – Feb 16, 2017 · Past) | Director · Mar 1, 2018 – Sep 30, 2020 · Past |
| Kurt M Eichler Other companies: DARA Biosciences Inc (Director · Feb 12, 2008 – Feb 12, 2008 · Past); MiMedx Group, Inc (Director · Feb 8, 2008 – Jul 27, 2012 · Past) | Director · May 5, 2016 – Jun 24, 2020 · Past |
| Garrett Winslow Other companies: Damora Therapeutics, Inc. (General Counsel · Since at least May 3, 2021) | General Counsel and Secretary · Mar 5, 2020 – Mar 5, 2020 · Past |
| Jonathan Freve Other companies: Damora Therapeutics, Inc. (Chief Financial Officer · Oct 28, 2020 – Jan 3, 2024 · Past) | CFO & Treasurer · May 5, 2016 – Mar 5, 2020 · Past |
| Lori Firmani Other companies: Damora Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 12, 2024) | VP of Finance and Treasurer · Apr 24, 2020 – Apr 24, 2020 · Past |
| Martin J Driscoll Other companies: MetaStat Inc (Director · Aug 5, 2015 – Aug 5, 2015 · Past) | President and CEO, Director · May 5, 2016 – Mar 5, 2020 · Past |
| Pamela M Klein Other companies: Jiya Acquisition Corp (Director · Nov 18, 2020 – Nov 18, 2020 · Past) | Director · Jul 10, 2019 – Jun 24, 2020 · Past |
All 14 people
| Person | Seat |
|---|---|
| Christiana Bardon | Director · Oct 26, 2017 – Oct 1, 2018 · Past |
| Jonathan Bates | Director · May 5, 2016 – Jun 18, 2018 · Past |
| Nezam H Afdhal | Chief Medical Officer · May 5, 2016 – Jan 24, 2019 · Past |
| Radhakrishnan P Iyer | Chief Scientific Officer · May 5, 2016 – Mar 5, 2020 · Past |
Log in to ask 6ix AI your own questions about Spring Bank Pharmaceuticals Inc.